AI-based quantification of TILs using hematoxylin and eosin and immunohistochemistry-stained slides in triple-negative breast cancer.

被引：0
|
作者：
Kobayashi, Takuma
Tomioka, Nobumoto
Hatanaka, Kanako C.
Konishi, Teppei
Grynkiewicz, Mateusz
Komura, Daisuke
Ishikawa, Shumpei
Watanabe, Kenichi
Takahashi, Masato
Hatanaka, Yutaka
机构：
[1] Biomy Inc, Tokyo, Japan
[2] Natl Hosp Org NHO Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ Hosp, Ctr Dev Adv Diagnost, Sapporo, Hokkaido, Japan
[4] Univ Tokyo, Dept Prevent Med, Grad Sch Med, Tokyo, Japan
[5] NHO Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan
[6] Hokkaido Univ Hosp, Dept Breast Surg, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13608
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Tumor-infiltrating lymphocytes (TILs) for prediction of response to platinum-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC): Final analysis
    Abdullaeva, S.
    Semiglazova, T. Y.
    Artemyeva, A.
    Kudaibergenova, A.
    Semiglazov, V.
    Krivorotko, P.
    Semiglazov, V.
    ANNALS OF ONCOLOGY, 2023, 34 : S288 - S289
  • [22] Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC)
    Williams, Matthew
    Peerani, Eleonora
    Tham, Elli
    Iori, Francesco
    de Fraine, George Richard Tiger Bevan
    Loughrey, Kerrie
    Kaffa, Andreas Dimitri
    Richardson, Thomas David Laurent
    Liberal, Carolina
    Velentza-Almpani, Angeliki
    Wiskerke, Demi Annemarie
    Sangkolah, Farah
    Crawley, Aston Martin
    Kearney, Jay
    Molina, Edgar Giussepi Lopez
    Bah, Nourdine Kabirou
    Tasoulis, Marios Konstantinos
    Kirwan, Cliona C.
    Ranatunga, Duleek Nimantha Bandara
    Hall, Peter Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Homologous recombination deficiency (HRD) status to predict the efficacy and prognosis of platinum-based neoadjuvant chemotherapy in patients with triple-negative breast cancer.
    Jin, Xuan
    Chen, Minyan
    Chen, Hanxi
    Chen, Lili
    Lin, Yuxiang
    Wu, Long
    Tang, Ganghuai
    Li, Weiwei
    Huang, Zhan
    Li, Qian
    Zhu, Changbin
    Guo, Wenhui
    Fu, Fangmeng
    Wang, Chuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Array-based identification of triple-negative breast cancer cells using fluorescent nanodot-graphene oxide complexes
    Tao, Yu
    Auguste, Debra T.
    BIOSENSORS & BIOELECTRONICS, 2016, 81 : 431 - 437
  • [25] Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort
    Qiu, Yu
    Chen, Yan
    Shen, Haoyang
    Yan, Shuixin
    Li, Jiadi
    Wu, Weizhu
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Effect of nodal status on clinical outcomes of triple-negative breast cancer: a population-based study using the SEER 18 database
    Wang, Xiao-Xiao
    Jiang, Yi-Zhou
    Li, Jun-Jing
    Song, Chuan-Gui
    Shao, Zhi-Ming
    ONCOTARGET, 2016, 7 (29) : 46636 - 46645
  • [27] Association of increased tumor-infiltrating lymphocytes (TILs) with immunomodulatory (IM) triple-negative breast cancer (TNBC) subtype and response to neoadjuvant platinum-based therapy in PrECOG0105.
    Vinayak, Shaveta
    Gray, Robert James
    Adams, Sylvia
    Jensen, Kristin C.
    Manola, Judith
    Afghahi, Anosheh
    Goldstein, Lori J.
    Ford, James M.
    Badve, Sunil S.
    Telli, Melinda L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Integrating machine learning algorithms and multiple immunohistochemistry validation to unveil novel diagnostic markers based on costimulatory molecules for predicting immune microenvironment status in triple-negative breast cancer
    Zhang, Chao
    Zhai, Wenyu
    Ma, Yuyu
    Wu, Minqing
    Cai, Qiaoting
    Huang, Jiajia
    Zhou, Zhihuan
    Duan, Fangfang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool
    Krishnamurthy, Savitri
    Jain, Parag
    Tripathy, Debu
    Basset, Roland
    Randhawa, Ramandeep
    Muhammad, Hassan
    Huang, Wei
    Yang, Hua
    Kummar, Shivaani
    Wilding, George
    Roy, Rajat
    JCO CLINICAL CANCER INFORMATICS, 2023, 7 : e2200181
  • [30] Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
    Kim, Soo-Yeon
    Lee, Jinsu
    Cho, Nariya
    Kim, Young-Gon
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345